Angiographic outcomes in the PLATO trial (Platelet inhibition and patient outcomes)

JACC: Cardiovascular Interventions

Volumn 6, Issue 7, 2013, Pages 671-683

  Kunadian, Vijay ^a   James, Stefan K ^b   Wojdyla, Daniel M ^c   Zorkun, Cafer ^d   Wu, Jinhui ^e   Storey, Robert F ^f   Steg, Ph Gabriel ^g,h,i   Katus, Hugo ^j   Emanuelsson, Hakan ^k   Horrow, Jay ^l   Maya, Juan ^l   Wallentin, Lars ^b   Harrington, Robert A ^m   Gibson, C Michael ⁿ  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UPPSALA UNIVERSITY   (Sweden)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d Istanbul Education and Research Hospital   (Turkey)

^e SICHUAN UNIVERSITY   (China)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

^g Institut National de la Sante   (France)

^h BICHAT HOSPITAL   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^k ASTRAZENECA R AND D   (Sweden)

^l ASTRAZENECA   (United Kingdom)

^m STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

clopidogrel; corrected TIMI frame count; Thrombolysis in Myocardial Infarction; ticagrelor; TIMI myocardial perfusion grade

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PLACEBO; TICAGRELOR;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTERY DIAMETER; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; CORONARY FLOW RESERVE; DOUBLE BLIND PROCEDURE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; LOADING DRUG DOSE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE AGGREGATION INHIBITION; THROMBUS; TREATMENT OUTCOME;

ACS; ACUTE CORONARY SYNDROMES; CLOPIDOGREL; CORRECTED TIMI FRAME COUNT; CTFC; INTERQUARTILE RANGE; IQR; MI; MYOCARDIAL INFARCTION; NON-ST-SEGMENT ELEVATION; NSTE; PCI; PD; PERCUTANEOUS CORONARY INTERVENTION; PHARMACODYNAMIC; ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEMI; THROMBOLYSIS IN MYOCARDIAL INFARCTION; TICAGRELOR; TIMI; TIMI MYOCARDIAL PERFUSION GRADE; TMPG;

ACUTE CORONARY SYNDROME; ADENOSINE; ADMINISTRATION, ORAL; AGED; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; CORONARY THROMBOSIS; CORONARY VESSELS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880277927     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.03.014     Document Type: Article

References (29)

1. L. Wallentin, R.C. Becker, A. Budaj PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
2. 12 receptor antagonist Ann Pharmacother 44 2010 524 537
3. 12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin Eur Heart J 27 2006 1038 1047
4. 12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes J Am Coll Cardiol 50 2007 1852 1856 (Pubitemid 350017792)
5. D.J. Schneider Mechanisms potentially contributing to the reduction in mortality associated with ticagrelor therapy J Am Coll Cardiol 57 2011 685 687
6. C.M. Gibson, D.J. Cohen, and E.A. Cohen Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy): Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy Am J Cardiol 87 2001 1293 1295 (Pubitemid 32493874)
7. A.S. Petronio, D. Rovai, and G. Musumeci Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty Eur Heart J 24 2003 67 76 (Pubitemid 36109548)
8. H.M. Gabriel, J.A. Oliveira, P.C. da Silva, J.M. da Costa, and J.A. da Cunha Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early Reopro Administration in Myocardial Infarction (ERAMI) trial Catheter Cardiovasc Interv 68 2006 218 224 (Pubitemid 44167671)
9. C.M. Gibson, D.A. Morrow, S.A. Murphy TIMI Study Group A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial J Am Coll Cardiol 47 2006 2364 2373 (Pubitemid 43884775)
10. 12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the Platelet Inhibition and Patient Outcomes (PLATO) trial Am Heart J 157 2009 599 605
11. C.M. Gibson, C.P. Cannon, and S.A. Murphy Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation 101 2000 125 130 (Pubitemid 30044249)
12. C.M. Gibson, C.P. Cannon, S.A. Murphy TIMI Study Group Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation 105 2002 1909 1913 (Pubitemid 34437617)
13. C.M. Gibson, C.P. Cannon, and W.L. Daley TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888 (Pubitemid 26074824)
14. TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial: phase I findings N Engl J Med 312 1985 932 936
15. C.M. Gibson, S.A. Murphy, and D.A. Morrow Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction Am Heart J 148 2004 336 340 (Pubitemid 39092802)
16. C.M. Gibson, J.A. de Lemos, and S.A. Murphy Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation 103 2001 2550 2554 (Pubitemid 32521963)
17. K. Vijayalakshmi, V.J. Whittaker, and B. Kunadian Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes Heart 92 2006 1278 1284 (Pubitemid 44298880)
18. M.G. Stoel, K.M. Marques, C.C. de Cock, J.G. Bronzwaer, C. von Birgelen, and F. Zijlstra High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study Catheter Cardiovasc Interv 71 2008 283 289 (Pubitemid 351428141)
19. J.J. Van Giezen, J. Sidaway, P. Glaves, I. Kirk, and J.A. Bjorkman Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model J Cardiovasc Pharmacol Ther 17 2012 164 172
20. A. Wittfeldt, H. Emanuelsson, and G. Brandrup-Wognsen Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans J Am Coll Cardiol 61 2013 723 727
21. K. Vijayalakshmi, B. Kunadian, and V.J. Whittaker Impact of catheter sizes and intracoronary glyceryl trinitrate on the TIMI frame count when digital angiograms are acquired at lower frame rates during elective angiography and PCI Acute Card Care 9 2007 231 238 (Pubitemid 350145789)
22. V. Kunadian, C. Zorkun, and S.P. Williams Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction J Thromb Thrombolysis 26 2008 234 242
23. 12 receptor antagonist, in healthy subjects Eur J Clin Pharmacol 66 2010 487 496
24. P.A. Gurbel, K.P. Bliden, and K. Butler Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study Circulation 120 2009 2577 2585
25. S.E. Husted, R.F. Storey, and K. Bliden Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studies Clin Pharmacokinet 51 2012 397 409
26. P.A. Gurbel, K.P. Bliden, and K. Butler Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study Circulation 121 2010 1188 1199
27. D. Alexopoulos, I. Xanthopoulou, and V. Gkizas Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction Circ Cardiovasc Interv 5 2012 797 804
28. 12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid Reversal of Platelet Thrombosis With Intravenous Elinogrel Before PCI To Optimize Reperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial Am Heart J 158 2009 998 1004.e1
29. D.J. Schneider Anti-platelet therapy: glycoprotein IIb-IIIa antagonists Br J Clin Pharmacol 72 2011 672 682